Filing Details
- Accession Number:
- 0001562180-20-001250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-14 17:09:12
- Reporting Period:
- 2020-02-12
- Accepted Time:
- 2020-02-14 17:09:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437152 | Karen Valentine | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-12 | 1,500 | $11.50 | 1,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-12 | 1,500 | $35.02 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-02-13 | 1,906 | $8.76 | 1,906 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-02-13 | 2,567 | $11.50 | 4,473 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-13 | 4,473 | $35.07 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-12 | 1,500 | $0.00 | 1,500 | $11.50 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-13 | 2,567 | $0.00 | 2,567 | $11.50 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-13 | 1,906 | $0.00 | 1,906 | $8.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
123,039 | 2028-07-18 | No | 4 | M | Direct | |
120,472 | 2028-07-18 | No | 4 | M | Direct | |
26,144 | 2029-03-06 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $35.00 to $35.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $35.00 to $35.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service.
- This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service.